A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Lyme Disease Antibodies (IgG, IgM), Immunoblot
Test Code8593
CPT Codes
86617 (x2)
Preferred Specimen
1 mL serum
Minimum Volume
0.5 mL
Instructions
Note: Administration of STRENSIQ may interfere in certain assays and may falsely elevate values. For patients receiving STRENSIQ, consideration should be given to using alternate methods.
Transport Container
Plastic screw-cap vial
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Gross lipemia
Methodology
Immunoblot (IB)
Setup Schedule
Set up: Tues-Sat; Report available: 1-4 days
Reference Range
Lyme Disease Ab (IgG), Blot | Negative |
Lyme Disease Ab (IgM), Blot | Negative |
Clinical Significance
Lyme disease is transmitted by a tick vector carrying Borrelia burgdorferi. Immunoblot testing qualitatively examines, with high specificity, antibodies in a patient's specimen. Immunoblot testing is appropriate for confirming a detected EIA or IFA test result.